Impact of computerized cognitive training on default mode network connectivity in subjects at risk for Alzheimer’s disease: a 78-week randomized controlled trial

Manuscript Number: 

22-0946R1

Author(s): 
Davangere Devanand, P. Murali Doraiswamy, Terry E. Goldberg, Andrew M. Michael, Adaora Nwosu, Jeffrey R. Petrella, Min Qian, Joel Sneed

Disclosures

Davangere Devanand

  • Consulting Fees:
    Acadia Paid to Dr. Devanand (Scientific Adviser) Eisai Paid to Dr. Devanand (Scientific Adviser) Jazz Paid to Dr. Devanand (Scientific Adviser) BioXcel Paid to Dr. Devanand (DSMB) Corium Paid to Dr. Devanand (Scientific Adviser) TauRx Paid to Dr. Devanand (Scientific Adviser) Biogen Paid to Dr. Devanand (Scientific Adviser)
    Grants
    • Agency: 
      Alzheimer's Association. Payments made to institution.
      Dates: 
      past 36 months

P. Murali Doraiswamy

  • Consulting Fees:
    Transposon, Clearview, Verily, Otsuka, Apollo, Lumos Labs, Cornell,
    Equity:
    UMethod, Evidation Health, Transposon, Alzheon, Marvel Biome.
    Lecture Fees:
    IMD
    Patents/Royalties
    Patents for diagnosis and treatment of dementia
    Grants
    • Agency: 
      Avanir, Blueberry Council, Bausch, Lilly
      Dates: 
      2022

Terry E. Goldberg

  • Nothing to Disclose

Andrew M. Michael

  • Nothing to Disclose

Adaora Nwosu

  • Nothing to Disclose

Jeffrey R. Petrella

  • Consulting Fees:
    Biogen cortechs.ai

Min Qian

  • Nothing to Disclose

Joel Sneed

  • Nothing to Disclose